| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |